Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Maintain ADD on Symphony - Domestic in line; RoW improving - HDFC Securities

Posted On: 2021-01-25 09:35:17 (Time Zone: Arizona, USA)

Mr. Naveen Trivedi, Institutional Research Analyst, HDFC Securities

Symphony's domestic revenue was in line (33% down YoY), while exports were down by 79% due to delays in shipment (bunch-up expected in 4Q). Thereby, 3QFY21 was below our estimates (down 40% YoY). Trade inventory is at a normal level (marginally lower) compared to last year. As a result, domestic revenue is expected to revive from 4Q onwards (new launches closer to the season). Trade sentiment is healthy and pent-up demand is also possible in the upcoming season (similar to other appliance categories). The Rest of the World (RoW) put up a weak show due to continued impact of COVID-19. CT delivered 1% growth in 9MFY21 while margin was impacted by supply constraints leading to high raw material cost. IMPCO and GSK are on the road to recovery, while gross margin was healthy. We have recently upgraded Symphony to ADD on the expectation of strong domestic recovery in the upcoming season and operational improvement for subsidiaries. We maintain EPS estimates for FY22/FY23. We value Symphony at 35x P/E on Mar-23E EPS and derive a TP of Rs 1,115. Maintain ADD.

Exports drag revenue: Standalone revenue declined by 40% YoY (+30% in 3QFY20 and -43% in 2QFY21), vs estimated decline of 25% YoY. The miss was primarily on account of exports. Domestic revenue declined 34% YoY (in-line) while exports saw a 79% YoY decline (HSIE +10%). High trade inventory kept domestic revenue weak. The company is taking several initiatives to revive domestic revenue, the result of which is expected to be visible in the upcoming season. RoW was down 13% YoY as the impact of COVID-19 was visible across markets. CT clocked 1% YoY growth in 9MFY21 while IMPCO and GSK continued to recover.

A miss in margins: Standalone GM remained flat YoY at 49.2% (+22bps in 3QFY20 and +103bps in 2QFY21) vs expectation of 122bps YoY expansion. Employee/ASP/Other expenses declined by 7/67/33% YoY. EBITDA margin contracted by 414bps YoY to 28.2% (+218bps in 3QFY20 and -539bps in 2QFY21), missing expectation of 199bps YoY dip. Standalone EBITDA declined by 48% YoY (HSIE -30%). PBT declined by 43% YoY while PAT declined by 40% YoY. RoW posted EBIT loss of Rs 70mn vs profit of Rs 90mn last year. Subsidiary margins continued to remain impacted. However, the company expects margins to improve from 4QFY21 onwards.

Call takeaways: (1) Channel inventory in India is higher since September but in line YoY; (2) consolidated inventory with the company was Rs 950mn while standalone inventory was Rs 350mn; (3) trade collection in Dec-20 was higher than Dec-19; (4) standalone sales in FY22 are expected to at least recover to FY20 level; (5) the company expects market share gains in the upcoming season due to supply chain constraints for other players.

Shares of Symphony Limited was last trading in BSE at Rs.1019.6 as compared to the previous close of Rs. 990.6. The total number of shares traded during the day was 8980 in over 831 trades.

The stock hit an intraday high of Rs. 1043.7 and intraday low of 962.9. The net turnover during the day was Rs. 8939175.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020